References
- World Health Organization. WHO Expert Consultation on Rabies. Third report. Geneva, Switzerland.: World Health Organization;2018. (WHO Technical Report Series, No.1012).
- Shi N, Zhang Y, Zheng H, Zhu Z, Wang D, Li S, Li Y, Yang L, Zhang J, Bai Y, et al. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects. Hum Vaccin Immunother. 2017;13(6):1338–45. doi:10.1080/21645515.2017.1279770.
- Chinese center for disease control and prevention. Technical guidelines for human rabies prevention and control. Chin J Viral Dis. 2016;6(3):161–88.
- WHO Expert Committee on Rabies. Guide for post-exposure treatment. Eighth report. WHO technical report 824. Geneva Switzerland: World Health Organization 1992.
- Huazhuang L, Guihua H, Qing C, Huai P. Adverse reaction and immune effect of domestic adjuvant-free rabies vaccine prepared with vero cells. Chin J Biol. 2008;21:327–28.
- Li Z, Jun G, Jianying H, Zhumu B, Deming Y. Safety and immune effect of adjuvant-free rabies vaccine. Chin J Biol. 2006;19:206–07.
- Ma J, Wang H, Li J, Chang L, Xie Y, Liu Z, Zhao Y, Malerczyk C. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the zagreb regimen (2-1-1) compared with the essen regimen in chinese adults. Hum Vaccin Immunother. 2014;10:2805–12. PMID:25483635. doi:10.4161/21645515.2014.972773.
- Mahendra BJ, Narayana DA, Agarkhedkar S, Ravish HS, Harish BR, Agarkhedkar S, Madhusudana SN, Belludi A, Ahmed K, Jonnalagedda R, et al. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen). Hum Vaccin Immunother 2015;11:428–34. doi:10.4161/21645515.2014.995059. PMID:25692792.
- Li R, Li Y, Wen S, Wen H, Nong Y, Mo Z, Xie F, Pellegrini M. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study. Hum Vaccin Immunother. 2015;11:435–42. PMID:25692350. doi:10.4161/21645515.2014.994460.
- Wang CL, Zhang XW, Yu YX. Study on the compliance and economic cost of rabies vaccination. Zhong Guo Yi Miao He Mian Yi. 2010;16:254–57. PMID:20726270.
- Hu Q, Liu MQ, Zhu ZG, Zhu ZR, Lu S. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vaccin Immunother. 2014;10:1645–49. PMID:24632727. doi:10.4161/hv.28420.
- Liu H, Huang G, Tang Q, Li J, Cao S, Fu C, Cao Q, Liu B, Pan H, Wang M, et al. The immunogenicity and safety of vaccination with purified vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vaccin Immunother 2011;7:220–24. doi:10.4161/hv.7.2.14003. PMID:21311216.
- Verma R, Khanna P, Prinja S, Rajput M. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost. Hum Vaccin Immunother. 2011;7:792–94. doi:10.4161/hv.7.7.15410.
- Schelermann N, Baer J, Hilfenhaus J, Marcus I, Zoulek G. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC) rabies vaccine in man. Zbl Bakt Hyg. 1987;265(3–4):439–50.
- Wang J, Luo F, Feng Z, Li L, Bai Y, Ai X, Ma J, Zhang Z, Shi N. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above. Hum Vaccin Immunother. 2017;13(1):144–50. doi:10.1080/21645515.2016.1230260.
- China Food and Drug Administration. The standard guidelines for adverse reactions grading of vaccine clinical trials. 2005 Oct 14. http://www.nmpa.gov.cn/WS04/CL2138/373037.html